Synapse - Christopher Forlenza

Search Within

Christopher Jon Forlenza

Results (51)

A survey of Children's Oncology Group Hodgkin Lymphoma members regarding the role of radiotherapy in the management of pediatric relapsed/refractory Hodgkin lymphoma

Meeting Abstract

Vega, R. M.; Harker-Murray, P. D.; Forlenza, C. J.; Cole, P.; Kelly, K. M.; Milgrom, S. A.; Parikh, R. R.; Hodgson, D.; Castellino, S.; Hoppe, B. S.
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML

Journal Article

Ramaswamy, K.; Steinherz, P. G.; Agrawal, A. K.; Forlenza, C. J.; Mauguen, A.; Roshal, M.; Trippett, T.; Kernan, N. A.; Sulis, M. L.; Shukla, N.
Blood Advances (2022)

Fulltext@MSK | Save

Impact of bridging chemotherapy on clinical outcomes of CD19-specific CAR T cell therapy in children/young adults with relapsed/refractory B cell acute lymphoblastic leukemia

Journal Article

Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Perica, K.; Park, J. H.; Forlenza, C. J.; Shukla, N. N.; Steinherz, P. G.; Margossian, S. P.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Vital organ sparing with proton therapy for pediatric Hodgkin lymphoma: Toxicity and outcomes in 50 patients

Journal Article

Tringale, K. R.; Modlin, L. A.; Sine, K.; Forlenza, C. J.; Cahlon, O.; Wolden, S. L.
Radiotherapy and Oncology (2022)

Fulltext@MSK | Save

Brentuximab vedotin as consolidation therapy following autologous stem cell transplantation in children and adolescents with relapsed/refractory Hodgkin lymphoma: A multi-center retrospective analysis

Meeting Abstract

Forlenza, C. J.; Rosenzweig, J.; Mauguen, A.; Buhtoiarov, I.; Cuglievan, B.; Dave, H.; Deyell, R. J.; Flerlage, J.; Franklin, A.; Krajewski, J.; more...
Blood (2021)

Fulltext@MSK | Save

Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma

Journal Article

Forlenza, C. J.; Gulati, N.; Mauguen, A.; Absalon, M. J.; Castellino, S. M.; Franklin, A.; Keller, F. G.; Shukla, N.
Blood Advances (2021)

Fulltext@MSK | Save

Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia

Meeting Abstract

Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
Pediatric Blood and Cancer (2021)

Fulltext@MSK | Save

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

Journal Article

Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
Nature Cancer (2021)

Fulltext@MSK | Save

Pediatric patients with relapsed/refractory acute lymphoblastic leukemia harboring heterogeneous genomic profiles respond to venetoclax in combination with chemotherapy

Meeting Abstract

Place, A. E.; Karol, S. E.; Forlenza, C. J.; Gambart, M.; Cooper, T. M.; Fraser, C.; Cario, G.; O'Brien, M. M.; Gerber, N. U.; Barnette, P.; more...
Blood (2020)

Fulltext@MSK | Save

Brentuximab vedotin plus bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma: A multi-institution retrospective analysis

Meeting Abstract

Forlenza, C. J.; Gulati, N.; Mauguen, A.; Absalon, M. J.; Castellino, S. M.; Franklin, A.; Keller, F. G.; Shukla, N.
Blood (2020)

Fulltext@MSK | Save